Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers,

BusinesswireJun 5 07:00 ET

Red Door Community Raises More Than $300,000 at Their Annual Luncheon Celebrating Women Working and Living With Cancer

Free cancer support programs get a boost, and Red Door Community member announces a run NEW YORK, May 17, 2024 /PRNewswire/ -- On Wednesday, May 15, Red Door Community hosted their annual Celebrating

PR NewswireMay 18 14:06 ET

Boundless Bio Inc. Shifts Corporate Updates to IR Website

TipRanksMay 13 07:22 ET

Boundless Bio, Inc. Q1 Loss Climbs

RTTNewsMay 13 07:17 ET

Boundless Bio | 10-Q: Quarterly report

SEC announcementMay 13 07:09 ET · Announcements

Express News | Boundless Bio Inc: First Patient Dosed in Phase 1/2 Starmap Clinical Trial of Bbi-825 in Patients With Tumors With Resistance Gene Amplifications

ReutersMay 13 07:07 ET